Abatement of potent P2Y12 antagonist-based dual antiplatelet therapy after coronary intervention: A network meta-analysis of randomized controlled trials.

El Alaoui El Abdallaoui, Oumaima; Tornyos, Dániel; Lukács, Réka; Komócsi, András

El Alaoui El Abdallaoui, Oumaima; Tornyos, Dániel; Lukács, Réka; Komócsi, András.

Afiliación

El Alaoui El Abdallaoui O; Doctoral School of Health Sciences, Faculty of Health Sciences, University of Pécs, Pécs, Hungary.
Tornyos D; Department of Interventional Cardiology, Heart Institute, Medical School, University of Pécs, Pécs, Hungary.
Lukács R; Department of Interventional Cardiology, Heart Institute, Medical School, University of Pécs, Pécs, Hungary.
Komócsi A; Department of Interventional Cardiology, Heart Institute, Medical School, University of Pécs, Pécs, Hungary.

Front Cardiovasc Med ; 9: 1008914, 2022.

Article en En | MEDLINE | ID: mdl-36712280

Palabras clave

P2Y12 de-escalation therapy; coronary intervention; network meta-analysis; prasugrel; ticagrelor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Systematic_reviews Idioma: En Revista: Front Cardiovasc Med Año: 2022 Tipo del documento: Article País de afiliación: Hungria Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google